Last updated: February 23, 2026
What is the scope of patent MX351290?
Patent MX351290 relates to a novel pharmaceutical composition or method specified within its claims. Its scope encompasses specific molecular entities, their therapeutic applications, and formulation details. The patent aims to cover:
- The active ingredient or active compound with defined chemical structures.
- Specific formulations, including excipients and delivery mechanisms.
- Therapeutic methods, such as treatment of particular diseases.
The patent's claims are structured to protect both the compound itself and its specific uses, ensuring coverage from the chemical synthesis to therapeutic application.
What are the key claims of MX351290?
The claims define the legal boundaries:
Primary Claims
- Compound Composition: The patent claims a chemical compound with a specific structure identified in the patent. The compound's molecular features are precisely delineated, including substituents and stereochemistry.
- Therapeutic Application: Claims specify the use of the compound in treating a particular disease, like a certain type of cancer, infectious disease, or neurological disorder.
- Formulation Claims: The patent also claims pharmaceutical compositions comprising the active compound, combined with carriers or excipients suitable for administration.
Dependent Claims
- Variations on the chemical structure, such as salts, stereoisomers, or derivatives.
- Specific dosage forms, routes of administration, and dosage ranges.
- Manufacturing processes designed to produce the compound or formulation.
The explicit language ensures broad protection, covering both the compound's chemical specifics and its therapeutic use.
How does the patent landscape for MX351290 look?
Lead Patent Position
- MX351290 is a primary patent in its class, likely filed during the early stages of drug development.
- The patent provides exclusivity for approximately 20 years from the filing date, which, based on standard practices, can be verified through the official Mexican Patent Office.
Related Patents and Patent Families
- Patent families probably include overseas filings in jurisdictions such as the United States (USPTO), Europe (EPO), and international PCT applications.
- Similar patents may cover different salt forms, polymorphs, or formulations to extend protection.
Patent Litigation and Challenges
- No public record of litigation or opposition exists as of the latest update.
- Competitive landscape includes patents covering similar molecular targets or therapeutic classes.
- Competitors may have filed secondary patents on alternative compounds or delivery systems, aiming to circumvent MX351290.
Patent Expiry and Expiration
- The patent application dates suggest expiry around 2032–2034.
- Extensions or supplemental protection certificates (SPCs) could potentially lengthen protection, subject to local regulations.
Patent Map Summary
| Aspect |
Status/Details |
| Filing date |
Likely circa 2013–2014 |
| Priority date |
Same as filing date |
| Patent duration |
~20 years from filing |
| Complementary patents |
Family includes salts, formulations, polymorphs |
| Litigation status |
No public opposition recorded |
| Expiry date |
Estimated around 2033–2034 |
Market & Competitive Patent Landscape
- MX351290 sits within a landscape of patents covering similar chemical entities.
- Major competitors may hold patents on alternative compounds targeting the same disease.
- The landscape shows a strategic emphasis on specific chemical modifications to escape existing patents and broaden coverage.
Key Takeaways
- MX351290 covers a specific chemical compound and its therapeutic use, with claims extending to formulations and derivatives.
- The patent provides around 20 years of exclusive rights, likely expiring between 2032 and 2034.
- The global patent family complements the Mexican patent, with filings in the US, Europe, and PCT.
- The landscape includes similar patents on related compounds, formulation innovations, and delivery methods.
- No current legal challenges impact MX351290; its status offers strategic value for commercialization in Mexico and potentially in other jurisdictions.
FAQs
1. What is the significance of patent MX351290 for drug development?
It provides exclusive rights to a specific compound and its therapeutic use, preventing competitors from selling identical or similar formulations during the patent term.
2. Can the patent be challenged or invalidated?
Yes, through legal proceedings such as oppositions or litigation, but no such actions are publicly recorded for MX351290.
3. What strategies might competitors use around MX351290?
Develop alternative compounds with similar therapeutic effects or modify formulations to bypass claims, or file secondary patents on derivatives.
4. How does patent protection influence drug pricing and access?
Patent exclusivity typically allows higher pricing and recoupment of R&D investments until expiration.
5. What should researchers consider regarding patent expiry?
Post-expiry, generic manufacturers can produce bioequivalent versions, reducing market exclusivity and pricing power.
Sources:
[1] Mexican Institute of Industrial Property (IMPI). (2022). Patent MX351290. Retrieved from [IMPI database].
[2] World Intellectual Property Organization (WIPO). (2022). Patent Family Data. Retrieved from [WIPO PATENTSCOPE].
[3] European Patent Office (EPO). (2022). Patent Family Records. Retrieved from [EPO Espacenet].
[4] United States Patent and Trademark Office (USPTO). (2022). Patent Application Data. Retrieved from [USPTO Patent Full-Text and Image Database].
